ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Suliqua 100/33, solution injectable - 3
66283003 Sanofi-Aventis (Suisse) SA
Suliqua 100/33, solution injectable05.10.2017
  05.10.2017
Insulin Glargine and Lixisenatide (A10AE54) 
WHO-DDD 
07.06.3
07.06. 
B  
Yes 
IPCI
70.76Yes
    
10 %97.75
7680662830035Biotechnologika
7298959 
Composition
insulinum glarginum 3.64 mg corresp. insulinum glarginum 100 U., lixisenatidum 33 µg, zinci chloridum, glycerolum (85 per centum), methioninum, conserv.: metacresolum 2.7 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Packungsbestandteile
Injection solution 
  
 
Active AgentDose
Insulin Glargine3.64 mg/ml correspond Insulin Glargine 100 U/ml
Lixisenatidum33 µg/ml
BAG: Active AgentDose
Insulin Glargine100 U
Lixisenatidum33 mcg
 
Inactive agentsDoseadditional_information
Glycerol  
Metacresol2.7 mg/mlconserv.
Methionine  
Zinc Chlorideate  
 
Source
Data was imported : 04.06.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home